Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma

Eye

Volumn 21, Issue 7, 2007, Pages 936-940

  Ansari, E ^a   Gandhewar, J ^b  

^a MAIDSTONE HOSPITAL   (United Kingdom)

^b ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; CATARACT; CONTROLLED STUDY; DIODE LASER; DISEASE COURSE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUBERCULOSIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 34447342542     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702345     Document Type: Article

References (17)

1. Hawkins TA, Stewart WC. One-year results of semiconductor transscleral cyclophotocoagulation in patients with glaucoma. Arch Ophthalmol 1993; 111: 488-491.
2. Kosoko O, Gaasterland DE, Pollack IP, Enger CL. Long term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. Ophthalmology 1996; 103: 1294-1302.
3. Bloom PA, Tsai JC, Sharma K, Miller MH, Rice NS, Hitchings RA et al. Cyclodiode: Transscleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology 1997; 104: 1508-1519.
4. Spencer AF, Vernon SA. 'Cyclodiode': Results of a standard protocol. Br J Ophthalmol 1999; 83: 311-316.
5. Egbert PR, Fiyadoyor S, Budenz DL, Dadzie P, Byrd S. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open angle glaucoma. Arch Ophthalmol 2001; 119: 345-350.
6. Lai JSM, Tham CCY, Chan JCH, Lam D. Diode laser transscleral cyclophotocoagulation as primary surgical treatment for medically uncontrolled chronic angle closure glaucoma. J Glaucoma 2005; 14(2): 114-119.
7. Brancato, R, Carassa RG, Bettin P. Contact transscleral cyclophotocoagulation with diode laser in refractory glaucoma. Eur J Ophthalmol 1995; 5: 32-39.
8. Benson MT, Nelson ME. Cyclocryotherapy: A review of cases over a 10 year period. Br J Opthalmol 1990; 74: 103-105.
9. Caprioli J, Strang SL, Spaeth GL. Cyclocryotherapy in the treatment of advanced glaucoma. Ophthalmology 1985; 92: 947-954.
10. Schuman JS, Bellows AR, Shingleton BJ. Contact transscleral Nd:YAG laser cyclophotocoagulation. Midterm results. Opphthalmology 1992: 99 1089-1095.
11. Dickens CJ, Nguyen N, Mora JS, Iwach AG, Gaffney MM, Wong PC et al. Long-term results of noncontact transscleral neodymium:YAG cyclophotocoagulation. Ophthalmology 1995; 102: 1777-1781.
12. Youn J, Cox TA, Herndon LW, Rand Allingham R, Shields MB. A Clinical comparison of transcleral cyclophotocoagulation with neodymium:YAg and semiconductor diode lasers. Am J Ophthalmol 1998; 12: 640-647.
13. Migdal C, Gregory W, Hitchings RA. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994; 101: 1651-1657.
14. Wilensky J, Kammer J. Long-term visual outcome of transscleral laser cyclotherapy in eyes with ambulatory vision. Ophthalmology 2004; 111: 1389-1392.
15. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 4. Comparison of treatment outcomes within race. Ophthalmology 1998; 105: 1146-1164.
16. Murphy CC, Burnett CAM, Spry PGD, Broadway DC, Diamond JP. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2003; 87: 1252-1257.
17. Wilson MR. A new role for diode laser transscleral cyclophotocoagulation? Arch Ophthalmol 2001; 119: 424-425.